Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Utah Medical Products (UTMD) Debt to Equity (2023 - 2025)

Utah Medical Products has reported Debt to Equity over the past 8 years, most recently at $0.0 for Q4 2025.

  • Quarterly results put Debt to Equity at $0.0 for Q4 2025, down 21.44% from a year ago — trailing twelve months through Dec 2025 was $0.0 (down 21.44% YoY), and the annual figure for FY2025 was $0.0, down 21.44%.
  • Debt to Equity for Q4 2025 was $0.0 at Utah Medical Products, down from $0.0 in the prior quarter.
  • Over the last five years, Debt to Equity for UTMD hit a ceiling of $0.0 in Q4 2024 and a floor of $0.0 in Q4 2025.
  • Median Debt to Equity over the past 3 years was $0.0 (2023), compared with a mean of $0.0.
  • Biggest five-year swings in Debt to Equity: increased 4.45% in 2024 and later fell 21.44% in 2025.
  • Utah Medical Products' Debt to Equity stood at $0.0 in 2023, then increased by 4.45% to $0.0 in 2024, then dropped by 21.44% to $0.0 in 2025.
  • The last three reported values for Debt to Equity were $0.0 (Q4 2025), $0.0 (Q3 2025), and $0.0 (Q4 2024) per Business Quant data.